Bis-aryl amide derivatives useful for the treatment of cancer

Details for Australian Patent Application No. 2008205252 (hide)

Owner Amgen Inc.

Inventors Potashman, Michele; Germain, Julie; D'Angelo, Noel; Booker, Shon; Harmange, Jean-Christophe; Kim, TaeSeong

Agent Shelston IP

Pub. Number AU-A-2008205252

PCT Pub. Number WO2008/086014

Priority 60/879,671 09.01.07 US

Filing date 9 January 2008

Wipo publication date 17 July 2008

International Classifications

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/4725 (2006.01)

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/086014 Priority application(s): WO2008/086014

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008205256-Two-probe bark control device and method for making such

2008205248-System and method for enhancing an activated sludge process